Actively Recruiting

Age: 19Years +
All Genders
ID07481110

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria

Led by Société Algérienne de Formation et Recherche en Oncologie · Updated on 2026-03-27

1000

Participants Needed

15

Research Sites

N/A

Total Duration

On this page

Sponsors

S

Société Algérienne de Formation et Recherche en Oncologie

Lead Sponsor

B

Bristol-Myers Squibb

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are conducting an observational study to understand the demographic, epidemiological, clinical, and outcome characteristics of patients with gastric cancer in Algeria. The study also aims to examine how these patients are diagnosed and treated in various oncology departments. The research gathers both prospective and retrospective data to provide a detailed overview of gastric cancer management in this population. This study collects data mainly through medical records and brief patient interviews lasting about 30 minutes. It involves approximately 1,000 patients with a confirmed diagnosis of gastric cancer. The data collection is non-interventional, meaning it does not involve any treatment or changes to patient care but focuses on describing existing diagnostic and therapeutic practices. Participants will provide information once during an initial visit, where researchers will assess demographic, sociological, epidemiological, and clinical features, along with disease progression. The study also records diagnostic methods and treatment approaches used. All collected data will be anonymized to protect patient privacy and used solely for research purposes. Participation duration corresponds to the initial data collection visit.

CONDITIONS

Brief Title

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 19 years and older
  • Histologically confirmed diagnosis of gastric cancer
  • Patients followed in the participating oncology departments
  • Informed consent obtained
Not Eligible

You will not qualify if you...

  • Histological types other than carcinoma (e.g., GIST, lymphoma, sarcoma, etc.)
  • Secondary gastric tumors
  • Participation in an interventional study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Diagnostic Evaluation

Duration - At initial visit

Participants undergo diagnostic assessments to confirm gastric cancer and collect relevant clinical data.

1 visit (in-person)

Surveillance

Duration - Cross-sectional at baseline

Participants who undergo routine care are observed and data are collected from medical records and brief interviews.

1 visit (in-person)

Trial Site Locations

Total: 15 locations

1

Cac Blida

Algiers, Algeria, Algeria, 16000

Not Yet Recruiting

2

CHU Béni Messous

Algiers, Algeria, Algeria, 16000

Actively Recruiting

3

CPMC

Algiers, Algeria

Not Yet Recruiting

4

EPH Rouiba

Algiers, Algeria

Not Yet Recruiting

5

CHU Annaba

Annaba, Algeria

Not Yet Recruiting

6

CHU Constantine

Constantine, Algeria

Not Yet Recruiting

7

EPH Constantine

Constantine, Algeria

Not Yet Recruiting

8

CAC Oued Souf

El Oued, Algeria

Not Yet Recruiting

9

CAC Oran

Oran, Algeria

Not Yet Recruiting

10

CHU Oran

Oran, Algeria

Not Yet Recruiting

11

EHU Oran

Oran, Algeria

Not Yet Recruiting

12

CAC Sétif

Sétif, Algeria

Not Yet Recruiting

13

CAC Sidi Bel Abbès

Sidi Bel Abbes, Algeria

Not Yet Recruiting

14

EPH Sidi Ghiles

Tipasa, Algeria

Not Yet Recruiting

15

CAC DBK

Tizi Ouzou, Algeria

Not Yet Recruiting

Loading map...

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Similar Trials

Phase III Randomized Controlled Trial Comparing D2 Versus D3...

Gastric Cancer

Actively Recruiting

1 location

Clinical Outcomes of Indocyanine Green Tracer in 3D Plus Ult...

Gastric Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here